Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
20,4 USD | -3,68% | -5,51% | +158,56% |
03/04 | JASPER THERAPEUTICS, INC. : Evercore ISI handhaaft koopadvies | ZM |
28/03 | JASPER THERAPEUTICS, INC. : RBC Capital Markets handhaaft koopadvies | ZM |
Omzet 2024 * | - | Omzet 2025 * | 6,29 mln. 5,88 mln. | Marktkapitalisatie | 308 mln. 288 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -71 mln. -66,4 mln. | Nettowinst (verlies) 2025 * | -74 mln. -69,21 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 217 mln. 203 mln. | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 49 x |
K/w-verhouding 2024 * |
-4,1
x | K/w-verhouding 2025 * |
-5,15
x | Werknemers | 45 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 93,36% |
Recentste transcriptie over Jasper Therapeutics, Inc.
1 dag | -3,68% | ||
1 week | -5,51% | ||
Lopende maand | -30,52% | ||
1 maand | -26,86% | ||
3 maanden | +74,36% | ||
6 maanden | +183,33% | ||
Lopend jaar | +158,56% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ronald Martell
CEO | Chief Executive Officer | 62 | 15-03-22 |
Herbert Cross
DFI | Director of Finance/CFO | 52 | 22-09-23 |
Luca Di Noto
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ronald Martell
CEO | Chief Executive Officer | 62 | 15-03-22 |
Thomas Wiggans
CHM | Chairman | 72 | 01/11 |
Kurt von Emster
BRD | Director/Board Member | 56 | 24-09-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 20,4 | -3,68% | 52 241 |
25-04-24 | 21,18 | -3,86% | 72 554 |
24-04-24 | 22,03 | -0,36% | 44 701 |
23-04-24 | 22,11 | -1,82% | 77 665 |
22-04-24 | 22,52 | +4,31% | 86 432 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+158,56% | 308 mln. | |
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |